2024 Q2 Form 10-Q Financial Statement

#000147793224002958 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $4.111M $3.190M
YoY Change 33.86% 7.08%
Cost Of Revenue $3.117M $2.666M
YoY Change 25.02% 20.05%
Gross Profit $993.8K $524.5K
YoY Change 72.02% -30.87%
Gross Profit Margin 24.18% 16.44%
Selling, General & Admin $799.2K $790.9K
YoY Change 2.06% -16.05%
% of Gross Profit 80.41% 150.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $171.4K $160.5K
YoY Change 4.8% 12.69%
% of Gross Profit 17.24% 30.61%
Operating Expenses $1.182M $1.155M
YoY Change 3.52% -7.1%
Operating Profit -$188.5K -$630.8K
YoY Change -24.81% 30.09%
Interest Expense $106.1K $27.49K
YoY Change 315.5% -47.96%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$82.45K -$563.2K
YoY Change -52.0% 9.84%
Income Tax -$12.50K $117.5K
% Of Pretax Income
Net Earnings -$69.95K -$445.7K
YoY Change -50.67% 31.96%
Net Earnings / Revenue -1.7% -13.97%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.07
COMMON SHARES
Basic Shares Outstanding 6.246M shares 6.246M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.231M $6.127M
YoY Change -23.89% -24.78%
Cash & Equivalents $4.668M
Short-Term Investments $1.496M $1.458M
Other Short-Term Assets $351.8K $336.6K
YoY Change 8.85% -30.45%
Inventory $300.2K $226.2K
Prepaid Expenses
Receivables $28.31K $13.26K
Other Receivables $0.00 $0.00
Total Short-Term Assets $5.911M $6.703M
YoY Change -19.94% -24.39%
LONG-TERM ASSETS
Property, Plant & Equipment $5.628M $3.225M
YoY Change 72.7% -2.1%
Goodwill $671.2K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $873.0K $928.3K
YoY Change -33.6% -32.2%
Other Assets $379.7K $372.3K
YoY Change 168.34% 232.69%
Total Long-Term Assets $8.119M $7.299M
YoY Change 4.47% -7.68%
TOTAL ASSETS
Total Short-Term Assets $5.911M $6.703M
Total Long-Term Assets $8.119M $7.299M
Total Assets $14.03M $14.00M
YoY Change -7.42% -16.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $612.6K $629.5K
YoY Change 52.88% 40.32%
Accrued Expenses $715.5K $399.9K
YoY Change 74.46% -24.9%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $164.4K $171.8K
YoY Change -1.1% 2.49%
Total Short-Term Liabilities $1.492M $1.415M
YoY Change 27.51% -33.67%
LONG-TERM LIABILITIES
Long-Term Debt $2.201M $2.238M
YoY Change -8.94% -15.83%
Other Long-Term Liabilities $1.630M $1.551M
YoY Change -7.98% -14.99%
Total Long-Term Liabilities $3.831M $2.238M
YoY Change 58.51% -15.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.492M $1.415M
Total Long-Term Liabilities $3.831M $2.238M
Total Liabilities $5.324M $5.204M
YoY Change -0.66% -21.35%
SHAREHOLDERS EQUITY
Retained Earnings -$2.496M
YoY Change 114.67%
Common Stock $12.49K
YoY Change -2.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.707M $8.797M
YoY Change
Total Liabilities & Shareholders Equity $14.03M $14.00M
YoY Change -7.42% -16.51%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$69.95K -$445.7K
YoY Change -50.67% 31.96%
Depreciation, Depletion And Amortization $171.4K $160.5K
YoY Change 4.8% 12.69%
Cash From Operating Activities $82.51K -$408.9K
YoY Change -117.4% 49.94%
INVESTING ACTIVITIES
Capital Expenditures $971.8K $112.4K
YoY Change 808.07% -12.63%
Acquisitions
YoY Change
Other Investing Activities $77.72K $50.10K
YoY Change -98.51% -100.95%
Cash From Investing Activities -$894.1K -$62.32K
YoY Change -117.52% -98.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $45.06K
YoY Change
Cash From Financing Activities -121.4K -$161.0K
YoY Change -90.56% -125.09%
NET CHANGE
Cash From Operating Activities 82.51K -$408.9K
Cash From Investing Activities -894.1K -$62.32K
Cash From Financing Activities -121.4K -$161.0K
Net Change In Cash -933.0K -$632.2K
YoY Change -127.9% -87.4%
FREE CASH FLOW
Cash From Operating Activities $82.51K -$408.9K
Capital Expenditures $971.8K $112.4K
Free Cash Flow -$889.3K -$521.3K
YoY Change 52.99% 29.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3225456 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3247013 usd
CY2024Q1 us-gaap Depreciation
Depreciation
133975 usd
CY2023Q2 us-gaap Depreciation
Depreciation
148364 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-122030 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
368970 usd
CY2024Q1 us-gaap Land
Land
435239 usd
CY2023Q4 us-gaap Land
Land
435239 usd
CY2024Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4101014 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3994685 usd
CY2024Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2469715 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2463626 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7005968 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6893550 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3521761 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3387786 usd
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001718224
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Entity File Number
EntityFileNumber
333-233233
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.002
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6461118 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
215000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6246118 shares
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
BT BRANDS, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1495764
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
405 Main Avenue West
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2D
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
West Fargo
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
ND
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
58078
CY2024Q1 dei City Area Code
CityAreaCode
307
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
274-3055
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6246118 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4668295 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5300446 usd
CY2024Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1458213 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1392060 usd
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
13263 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
28737 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
226218 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
201333 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
77824 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47246 usd
CY2024Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
258751 usd
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
258751 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
6702564 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
7228573 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3225456 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3247013 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1732525 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1789285 usd
CY2024Q1 us-gaap Investments
Investments
928306 usd
CY2023Q4 us-gaap Investments
Investments
1022806 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
323500 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
206000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
671220 usd
CY2023Q4 us-gaap Goodwill
Goodwill
671220 usd
CY2024Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
368970 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
395113 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
48776 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
49202 usd
CY2024Q1 us-gaap Assets
Assets
14001317 usd
CY2023Q4 us-gaap Assets
Assets
14609212 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
629504 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
555247 usd
CY2024Q1 btbd Broker Margin Loan
BrokerMarginLoan
0 usd
CY2023Q4 btbd Broker Margin Loan
BrokerMarginLoan
115899 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
171782 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
183329 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
213995 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
215326 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
399906 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
480289 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1415187 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1550090 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2237610 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2269771 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1551491 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1600622 usd
CY2024Q1 us-gaap Liabilities
Liabilities
5204288 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5420483 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.002
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6461118 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6246118 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
12492 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12492 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
215000 shares
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
357107 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
357107 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11637235 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11583235 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2495591 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2049891 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
8797029 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
9188729 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14001317 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14609212 usd
CY2024Q1 us-gaap Revenues
Revenues
3190147 usd
CY2023Q2 us-gaap Revenues
Revenues
3070798 usd
CY2024Q1 btbd Food And Paper Costs
FoodAndPaperCosts
1278958 usd
CY2023Q2 btbd Food And Paper Costs
FoodAndPaperCosts
1290323 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1386686 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1202760 usd
CY2024Q1 us-gaap Occupancy Net
OccupancyNet
336275 usd
CY2023Q2 us-gaap Occupancy Net
OccupancyNet
357125 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
203900 usd
CY2023Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
195614 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
160542 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
163507 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
454615 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
425915 usd
CY2024Q1 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
CY2023Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-313688 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
3820976 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
3321556 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-630829 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-250758 usd
CY2024Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
114763 usd
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
69856 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
27488 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
25533 usd
CY2024Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
74854 usd
CY2023Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
89048 usd
CY2024Q1 btbd Equity In Loss Of Affiliate
EquityInLossOfAffiliate
-94500 usd
CY2023Q2 btbd Equity In Loss Of Affiliate
EquityInLossOfAffiliate
-54399 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-563200 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-171786 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
117500 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-445700 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-141786 usd
CY2024Q1 btbd Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.07
CY2023Q2 btbd Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.02
CY2024Q1 btbd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
6246118 shares
CY2023Q2 btbd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
6280729 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10152622 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-141786 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
35900 usd
CY2023Q2 btbd Treasury Stock Purchase Amount
TreasuryStockPurchaseAmount
-250225 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9796511 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
9188729 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-445700 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
54000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
8797029 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-445700 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-141786 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
160542 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
163507 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1350 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1350 usd
CY2024Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-117500 usd
CY2023Q2 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-30000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
54000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
35900 usd
CY2024Q1 btbd Unrealized Gain Loss On Marketable Securities
UnrealizedGainLossOnMarketableSecurities
-114763 usd
CY2023Q2 btbd Unrealized Gain Loss On Marketable Securities
UnrealizedGainLossOnMarketableSecurities
-69856 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1487 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-29177 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
94500 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
54399 usd
CY2024Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
6298 usd
CY2023Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
4736 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
0 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
313688 usd
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
15474 usd
CY2023Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
62352 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24885 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14656 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-30578 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-27027 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
74257 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-47894 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-80383 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-122419 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-408875 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-474259 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
496000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
112416 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
107017 usd
CY2024Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5370898 usd
CY2023Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1026917 usd
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5276398 usd
CY2023Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5741908 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62319 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5103974 usd
CY2024Q1 btbd Payment On Margin Loan To Finance Purchase Of Marketable Securities
PaymentOnMarginLoanToFinancePurchaseOfMarketableSecurities
-115899 usd
CY2023Q2 btbd Payment On Margin Loan To Finance Purchase Of Marketable Securities
PaymentOnMarginLoanToFinancePurchaseOfMarketableSecurities
-791370 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
45058 usd
CY2023Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
244297 usd
CY2024Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 usd
CY2023Q2 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
250225 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-160957 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1285892 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-632151 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3343823 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5300446 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2150578 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4668295 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5494401 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
26138 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
24183 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, and the differences could be material.</p>
CY2024Q1 btbd Remaining Value Of Intangible Asset
RemainingValueOfIntangibleAsset
440384 usd
CY2023Q2 btbd Common Shares
CommonShares
11095085 shares
CY2022Q2 btbd Equity Method Investments Ownership Percentage
EquityMethodInvestmentsOwnershipPercentage
0.412 pure
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1390000 usd
CY2022Q2 btbd Warrant Excercise Price
WarrantExcercisePrice
0.114
CY2024Q1 btbd Asset Held For Salepolicytextblock
AssetHeldForSalepolicytextblock
<p style="font-size:10pt;font-family:times new roman;margin:0px">We closed a Burger Time store in Richmond, Indiana, in 2018. In February 2023, we completed the sale of our former West St. Paul location for a gain reported in the first quarter of 2023 of $313,688. The Richmond location is currently offered for sale. We believe the Richmond property will be sold at or above its current carrying value.</p>
CY2023Q1 us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
313688 usd
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.275 pure
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
491000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
491000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-95887 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
395113 usd
CY2024Q1 us-gaap Exploration Expense
ExplorationExpense
26143 usd
CY2023Q2 us-gaap Exploration Expense
ExplorationExpense
14718 usd
CY2024Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
258751 usd
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
258751 usd
CY2024Q1 btbd Accrued Real Estate Taxes
AccruedRealEstateTaxes
23733 usd
CY2023Q4 btbd Accrued Real Estate Taxes
AccruedRealEstateTaxes
49357 usd
CY2024Q1 btbd Accrued Bonus Compensation
AccruedBonusCompensation
0 usd
CY2023Q4 btbd Accrued Bonus Compensation
AccruedBonusCompensation
119139 usd
CY2024Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
199201 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
149587 usd
CY2024Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
7989 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
11343 usd
CY2024Q1 btbd Accrued Sales Taxes Payable
AccruedSalesTaxesPayable
103914 usd
CY2023Q4 btbd Accrued Sales Taxes Payable
AccruedSalesTaxesPayable
81683 usd
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
17663 usd
CY2024Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
17663 usd
CY2024Q1 btbd Accured Gift Card Liability
AccuredGiftCardLiability
23819 usd
CY2023Q4 btbd Accured Gift Card Liability
AccuredGiftCardLiability
26844 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
23587 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
24673 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
399906 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
480289 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2444241 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2489299 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-34849 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-36199 usd
CY2024Q1 btbd Current Maturities Notes Payable
CurrentMaturitiesNotesPayable
-171782 usd
CY2023Q4 btbd Current Maturities Notes Payable
CurrentMaturitiesNotesPayable
-183329 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2237610 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2269771 usd
CY2024Q1 btbd Shares Available For A Grant
SharesAvailableForAGrant
779750 shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P7Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P5Y
CY2024Q1 btbd Descrption Of Agrrement
DescrptionOfAgrrement
we project approximately $144,000 in stock-based compensation will be recognized at the rate of $32,000 per year in each of the first four years and $16,000 will be recognized in 2028
CY2024Q1 btbd Project Net Amount
ProjectNetAmount
120000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
220250 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.74
CY2023Q2 btbd Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
P9Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
220250 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.74
CY2023Q2 btbd Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermOutstanding
P8Y10M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
94950 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.18
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y10M24D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
319500 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.62
CY2024Q1 btbd Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
P7Y9M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
319500 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.62
CY2024Q1 btbd Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermOutstanding
P7Y4M24D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
106802 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.18
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2024Q1 btbd Contingent Incentive Share Award Description
ContingentIncentiveShareAwardDescription
The Contingent Incentive Share Awards provides that so long as the Company’s publicly traded warrants are outstanding, senior management of the Company will be deemed to earn an aggregate award of 250,000 shares of common stock as an award upon the Company’s share price reaching $8.50 per share for 20 consecutive trading days, provided, however, participants must be employed by the Company at the time the Incentive Shares are earned
CY2023Q1 btbd Granted Options To Purchase
GrantedOptionsToPurchase
250000 shares
CY2023Q1 btbd Share Prices Increased
SharePricesIncreased
8.50
CY2023 btbd Share Award Estimated Expense
ShareAwardEstimatedExpense
265000 usd
CY2024Q1 btbd Contingent Incentive Share Award
ContingentIncentiveShareAward
31000 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9500 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
160000 usd
CY2024Q1 btbd Lease Weighted Average Remaining Lease Term
LeaseWeightedAverageRemainingLeaseTerm
P5Y
CY2024Q1 btbd Incremental Borrowing Rate
IncrementalBorrowingRate
0.0432 pure
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
217679 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
297436 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
306356 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
258512 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
209233 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
816797 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2106013 usd
CY2024Q1 btbd Operating Leases Future Minimum Interest
OperatingLeasesFutureMinimumInterest
-340527 usd
CY2024Q1 btbd Present Value Of Lease Payments
PresentValueOfLeasePayments
1765486 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
85000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
81000 usd
CY2024Q1 us-gaap Short Term Lease Payments
ShortTermLeasePayments
79000 usd
CY2023Q1 us-gaap Short Term Lease Payments
ShortTermLeasePayments
76000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
9.000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
8500 usd
CY2024Q1 btbd Monthly Rent
MonthlyRent
2200 usd
CY2024Q1 us-gaap Investment Sold Not Yet Purchased Balance Shares
InvestmentSoldNotYetPurchasedBalanceShares
358000 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00

Files In Submission

Name View Source Status
0001477932-24-002958-index-headers.html Edgar Link pending
0001477932-24-002958-index.html Edgar Link pending
0001477932-24-002958.txt Edgar Link pending
0001477932-24-002958-xbrl.zip Edgar Link pending
btbd-20240331.xsd Edgar Link pending
btbd-20240331_def.xml Edgar Link unprocessable
btbd_10q.htm Edgar Link pending
btbd_10qimg2.jpg Edgar Link pending
btbd_ex311.htm Edgar Link pending
btbd_ex312.htm Edgar Link pending
btbd_ex321.htm Edgar Link pending
btbd_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
btbd-20240331_lab.xml Edgar Link unprocessable
btbd-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
btbd_10q_htm.xml Edgar Link completed
btbd-20240331_cal.xml Edgar Link unprocessable